Tonghua Dongbao Pharmaceutical
Pre-Approval PRO BETASlowing Activity
No new clinical trials started in 1-2 years. Monitor for changes in pipeline strategy. Last trial started: 1/6/2025
Pipeline by Phase
Therapeutic Focus
Clinical Trials (11)
Efficacy and Safety of THDB0206 Compared to Insulin Lispro Injection in Participants With Type 2 Diabetes
Started: 5/6/2022
Efficacy and Safety of THDB0206 Compared to Insulin Lispro Injection in Participants With Type 1 Diabetes
Started: 4/13/2022
A Trial Investigating the Efficacy and Safety of Insulin Degludec/Liraglutide Injection in Subjects With Type 2 Diabetes
Started: 8/1/2024
A Phase III Study of Insulin Aspart Injection to Evaluate the Efficacy and Safety
Started: 6/19/2015
Phase II Study of THDBH120 Injection in Overweight or Obese Subjects
Started: 1/6/2025
A Trial to Investigate the Single Dose Pharmacokinetics of Insulin Degludec/Liraglutide in Healthy Chinese Subjects
Started: 5/6/2024
Comparative PK/PD of Single-Dose THDB0206 at Different Injection Sites
Started: 4/17/2024
Multiple Dose Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of THDBH120 in Chinese Patients With T2DM
Started: 6/13/2024
Multiple Dose Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of THDBH120 in Chinese Patients With Obesity
Started: 7/18/2024
A Single- and Multiple-Ascending Dose Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of THDBH120 Injection in Healthy Subjects
Started: 12/19/2023
A Trial to Evaluate the Pharmacokinetics and Pharmacodynamics of THDB0206 Injection in Healthy Chinese Subjects
Started: 6/17/2021